"Paraproteinemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
| Descriptor ID |
D010265
|
| MeSH Number(s) |
C15.378.147.780 C20.683.780
|
| Concept/Terms |
Paraproteinemias- Paraproteinemias
- Paraproteinemia
- Paraimmunoglobulinemias
- Paraimmunoglobulinemia
Plasma Cell Dyscrasias- Plasma Cell Dyscrasias
- Cell Dyscrasia, Plasma
- Cell Dyscrasias, Plasma
- Dyscrasia, Plasma Cell
- Dyscrasias, Plasma Cell
- Plasma Cell Dyscrasia
Gammopathy, Monoclonal- Gammopathy, Monoclonal
- Gammopathies, Monoclonal
- Monoclonal Gammopathy
- Monoclonal Gammopathies
- Gammapathy, Monoclonal
- Gammapathies, Monoclonal
- Monoclonal Gammapathy
- Monoclonal Gammapathies
|
Below are MeSH descriptors whose meaning is more general than "Paraproteinemias".
Below are MeSH descriptors whose meaning is more specific than "Paraproteinemias".
This graph shows the total number of publications written about "Paraproteinemias" by people in this website by year, and whether "Paraproteinemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Paraproteinemias" by people in Profiles.
-
Monoclonal Gammopathy-Associated Neuropathy. Curr Hematol Malig Rep. 2024 Dec 16; 20(1):2.
-
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood Cancer J. 2024 03 06; 14(1):38.
-
The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study. BMC Cancer. 2024 Feb 05; 24(1):174.
-
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6. Blood Cancer J. 2022 04 13; 12(4):60.
-
When a Monoclonal Gammopathy Is Not Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-10.
-
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study. Lancet Haematol. 2022 May; 9(5):e340-e349.
-
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):297-304.
-
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series. Am J Kidney Dis. 2022 02; 79(2):202-216.
-
Clinicopathologic Assessment of Monoclonal Immunoglobulin-associated Renal Disease in the Kidney Allograft: A Retrospective Study and Review of the Literature. Transplantation. 2020 07; 104(7):1341-1349.
-
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 02; 95(2):281-295.